When you take Tirzepatide, the fat loss moves faster than the calorie math alone would suggest.
Faster than you’d expect from the deficit alone.
Yesterday I sent out an email about this.
But there’s another reason for the accelerated fat loss that I didn’t mention in that email.
Researchers at the Pennington Biomedical Research Center published a study in Cell Metabolism earlier this year specifically designed to figure out what tirzepatide is actually doing beyond appetite suppression.
Here’s what they found.
Participants on tirzepatide showed a meaningful shift in how their bodies were burning fuel. Specifically, a significant increase in fat oxidation.
The body started preferentially burning fat as its primary energy source rather than carbohydrates or protein.
They measured this through something called respiratory quotient, basically a real-time readout of what your body is using for fuel.
Lower values mean more fat being burned… and Tirzepatide pushed those values down consistently, both during the day and during sleep.
The lead researcher, Dr. Eric Ravussin, put it plainly: “Our research indicates that tirzepatide not only facilitates substantial weight loss but also enhances fat oxidation.” [1]
So two separate mechanisms are running at the same time.
The food noise goes quiet, you eat less without fighting yourself, and the deficit happens naturally.
That’s the part most people already know about.
But simultaneously, your body shifts its fuel preference toward fat.
When your body is pulling from fat stores at a higher rate, that’s less muscle being sacrificed to meet the deficit.
You end up being leaner, with better body composition, not just lighter.
If you want to experience this yourself, Kino Clinic is where to start. Pharmacy-grade compounded Tirzepatide. $179 per month.
Fill out a quick online form, a licensed physician reviews it, and if approved, your medication arrives within 3-5 business days. No phone calls, no video appointments.
Start Your Protocol at Kino Clinic
Talk soon,
Greg O’Gallagher
Kino Clinic works exclusively with licensed 503A compounding pharmacies to provide physician-prescribed, pharmacy-grade compounded Tirzepatide. All medications are prescribed by licensed physicians for individually identified patients based on documented clinical need. Compounded medications are not FDA-approved finished drug products and are not intended as substitutes for FDA-approved medications such as Mounjaro® or Zepbound®. Individual results vary. This is not medical advice. Use only under the supervision of a licensed healthcare provider.
© 2026 Kino Clinic. All rights reserved.